Skip to content

Thorsten Barnhofer

Department of Psychological Interventions, School of Psychology, University of Surrey, Guildford, UK. Electronic address: t.barnhofer@surrey.ac.uk.

4 papers in the library · 25 citations · publishing 2023-2026

Papers

Effects of a mindfulness-based intervention and a health self-management programme on psychological well-being in older adults with subjective cognitive decline: Secondary analyses from the SCD-Well randomised clinical trial.

PloS one January 1, 2023 Marco Schlosser, Harriet Demnitz-King, Thorsten Barnhofer et al. 13 citations

Older adults with subjective cognitive decline (SCD) recruited from memory clinics are at higher risk for dementia and often have reduced well-being due to memory concerns and fear of dementia. A randomized trial compared an 8-week caring mindfulness-based approach for seniors (CMBAS) with a health self-management program (HSMP) in 147 participants. The mindfulness program showed a small advantage over HSMP in improving a sense of connection immediately after the intervention. However, overall psychological well-being, quality of life, and other composite measures did not increase in either group. The findings suggest that these brief non-pharmacological interventions had only limited effects on well-being in SCD.

Mindfulness-based cognitive therapy versus treatment as usual after non-remission with NHS Talking Therapies high-intensity psychological therapy for depression: a UK-based clinical effectiveness and cost-effectiveness randomised, controlled, superiority trial.

The lancet. Psychiatry June 1, 2025 Thorsten Barnhofer, Barnaby D Dunn, Clara Strauss et al. 9 citations

About half of patients with depression who complete the UK National Health Service Talking Therapies stepped care pathway still have symptoms. A randomized trial tested whether adding mindfulness-based cognitive therapy (MBCT) via videoconference to treatment as usual improves outcomes for these patients. At 34 weeks, the MBCT group had significantly lower depression scores than the treatment-as-usual group (adjusted difference -2.49 points on the PHQ-9). The MBCT group also had slightly lower healthcare costs and higher quality-of-life scores, with a 99% chance of being cost-effective at the £20,000 per QALY threshold. No serious adverse events occurred. MBCT is an effective and scalable further-line treatment for depression that does not remit after psychological therapy.

Investigating change in the ability to decentre and depressive symptomatology over the course of a six-month mindfulness-based intervention in patients with persistent depression.

Psychiatry research November 1, 2024 Jonathan Hamilton, Thorsten Barnhofer 2 citations

Decentering skills, the core ability cultivated in mindfulness-based interventions, continue to increase over six months of practice and drive reductions in depressive symptoms. In a blended online and in-person program, 44 adults with persistent depression provided self-reports at three time points. Thirty-one participants completed the intervention, averaging 68.6% of assigned practices. Statistical modeling showed that changes in decentering preceded and predicted later symptom improvements, suggesting that longer practice periods help move patients closer to recovery or remission.

Efficacy and Moderators of Mindfulness-Based Cognitive Therapy in Difficult-to-Treat Depression: A Systematic Review and Individual Participant Data Meta-Analysis

Psychotherapy and Psychosomatics June 12, 2026 Thorsten Barnhofer, Maria Niemi, Johannes Michalak et al. 1 citation

For adults with difficult-to-treat depression—those who have not responded to prior treatments, have treatment-resistant depression, or have a chronic course—mindfulness-based cognitive therapy (MBCT) is likely superior to usual care, reducing depressive symptoms by a standardized mean difference of -0.40 at post-treatment and -0.41 at medium-term follow-up. There was a 92% and 85% probability, respectively, that these benefits exceeded a minimal important difference. However, MBCT did not show clear superiority over other active psychosocial interventions, and no robust moderators of outcome were identified across baseline severity, chronicity, or comorbidity.